Literature DB >> 25830995

Concurrence of Sweet's syndrome, pathergy phenomenon and erythema nodosum-like lesions.

Jianjun Qiao1, Yan Wang1, Juan Bai1, Yinhua Wu1, Hong Fang1.   

Abstract

We report the case of a 54-year-old woman with concurrent Sweet's syndrome, pathergy phenomenon and eythema nodosum-like lesions associated with suppurative tonsillitis. Tender, violaceous and highly edematous papules and plaques were detected on the forearms and legs, some of which were pseudovesicular. Similar edematous papules were detected on the dorsum of the hands at the sites of intravenous injection. Biopsies of a plaque on the forearm and a papule at the site of intravenous injection confirmed the presence of Sweet's syndrome. Multiple, tender, violet-red, subcutaneous erythematous nodules were revealed on the legs. A biopsy taken from a nodule on the leg revealed septal panniculitis. To our knowledge, no patient with concurrent Sweet's syndrome, pathergy phenomenon, and erythema nodosum-lesions had been reported yet in previous literature.

Entities:  

Mesh:

Year:  2015        PMID: 25830995      PMCID: PMC4371674          DOI: 10.1590/abd1806-4841.20153201

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


INTRODUCTION

Sweet's syndrome, also named as acute febrile neutrophilic dermatosis, is clinically characterized by the abrupt development of painful erythematous papules and plaques that can be pseudovesicular. Fever, arthralgias, leukocytosis with neutrophilia, elevated C-reactive protein and erythrocyte sedimentation rate may occur.[1-4] Erythema nodosum is a form of septal granulomatous panniculitis characterized by abruptly developing painful red nodules mainly over the pretibial area.[1,5] Concurrence of the two reactive cutaneous conditions seems to be infrequently reported. Pathergy is defined as an induction of dermatosis-associated skin lesions appearing at sites of skin trauma.[2,6] The pathergy phenomenon in Sweet's syndrome patients is rarely reported. We reported the case of a patient with simultaneous occurrence of Sweet's syndrome associated with pathergy and erythema nodosum-like lesions. To our knowledge, no patient with concurrent Sweet's syndrome, pathergy phenomenon, and erythema nodosum-lesions had yet been reported in previous literature.

CASE REPORT

A 54-year-old woman presented with a 7-day history of painful erythematous lesions on the lower and upper extremities. These lesions were preceded by a one-day history of sore throat and fever. Suppurative tonsillitis had been confirmed by an otolaryngologist. Her past medical history did not reveal any previous disease. Intravenous levofloxacin had been given to control the tonsillitis. Lesions similar to those on the upper extremities occurred on the dorsum of the hands at the sites of intravenous injection. Physical examination revealed a temperature of 39ºC. Tender, violaceous and highly edematous papules and plaques were detected on the forearms and legs, some of which were pseudovesicular (Figures 1A and 1B). Similar edematous papules were detected on the dorsum of the hands at the sites of intravenous injection (Figure 1C). Multiple, tender, violet-red, subcutaneous erythematous nodules were revealed on the legs (Figure 1D).
FIGURE 1

A. Eruptions of Sweet’s syndrome with pathergy phenomenon and erythema nodosumlike lesions. (a) Pseudovesicular plaques on the arm and the leg; B. Pseudovesicular plaques on the leg; C. Pathergy phenomenon at the site of intravenous injection on the dorsum of the left hand; D. Erythema nodosum - like lesions on the legs

A. Eruptions of Sweet’s syndrome with pathergy phenomenon and erythema nodosumlike lesions. (a) Pseudovesicular plaques on the arm and the leg; B. Pseudovesicular plaques on the leg; C. Pathergy phenomenon at the site of intravenous injection on the dorsum of the left hand; D. Erythema nodosum - like lesions on the legs Her peripheral blood neutrophil count was elevated at 11.1×10[9]/L [normal, (4 to 10) ×10[9]/L], with a neutrophilic predominance of 81.4%. She had an elevated C-reactive protein level (27 mg/L; normal, 0 to 8 mg/L) and erythrocyte sedimentation rate (31 mm/h; normal, 0 to 20 mm/h). Skin a plaque on the forearm and a papule at the site of intravenous injection, were consistent with Sweet's syndrome. They showed prominent edema on the upper dermis and a diffuse neutrophil-rich infiltrate in the upper and mid dermis with leukocytoclasis (Figure 2A). A biopsy taken from a nodule on the leg revealed septal panniculitis with infiltrate of neutrophils, histiocytes and giant cells. The pathological change was consistent with erythema nodosum (Figure 2B).
FIGURE 2

A. Histopathological manifestation of Sweet’s syndrome. Prominent edema in the upper dermis and dense neutrophilic infiltrate (H&E, original magnification x40); B. Biopsy of erythema nodosum-like lesion showed septal panniculitis with infiltrate of neutrophils, histiocytes and giant cells (H&E, original magnification x100)

With these clinical and histopathologic findings, a diagnosis of Sweet's syndrome with pathergy phenomenon and erythema nodosum-like lesions was made. A. Histopathological manifestation of Sweet’s syndrome. Prominent edema in the upper dermis and dense neutrophilic infiltrate (H&E, original magnification x40); B. Biopsy of erythema nodosum-like lesion showed septal panniculitis with infiltrate of neutrophils, histiocytes and giant cells (H&E, original magnification x100) The patient was given methylprednisolone at a dose of 40 mg per day to control the cutaneous conditions. She had a dramatic response with complete resolution of her fever and skin lesions in 10 days. The peripheral blood leukocyte count, C-reactive protein level, and erythrocyte sedimentation rate recovered normal range.

DISCUSSION

Our patient presented with two unusual clinical features. First, Sweet's syndrome and erythema nodosum-like lesions appeared simultaneously. Second, the obvious cutaneous pathergy occurred, i.e. lesions occurred at the sites of intravenous injection. To our knowledge, no patient of Sweet's syndrome with pathergy phenomenon and concurrent erythema nodosum-lesions had yet been reported in previous literature. Sweet's syndrome and erythema nodosum share many similar clinical and histological features.[1-3,7,8] Both have acute onset and occur in association with many of the same systemic conditions, such as upper respiratory infections, medications, hematologic malignancies, and autoimmune disease.[2,5,8] The two conditions are responsive to similar therapeutic drugs as systemic glucocortioids or potassium iodide.[2,5,7,9] Recently 16 cases of biopsy-confirmed occurrence of Sweet's syndrome and erythema nodosum-like lesions were well reviewed.[7] Nonetheless there are some differences between Sweet's syndrome and erythema nodosum.[1,2,5,7,9] Sweet's syndrome lesions mainly involve the upper part of the body - head, neck, shoulder and trunk, while erythema nodosum lesions are characteristically seen on the pretibial region.[2,5] Erythema nodosum lesions reveal deeper inflammatory cell infiltrate in subcutaneous adipose tissue, though this infiltrate is more superficial in dermis in Sweet's syndrome lesions.[2,5] A recently proposed entity subcutaneous Sweet's syndrome referred to those whose neutrophilic infiltrate is located in the subcutaneous adipose tissue only, including the lobule, septa, or both.[10] According to this proposal, erythema nodosumlike lesions in Sweet's syndrome patients may be a subcutaneous variant of Sweet's syndrome. This case also illustrates an association of the pathergy phenomenon with Sweet's syndrome. Pathergy in Sweet's syndrome patients is rarely reported.[2] The pathogenesis of the pathergy in Sweet's syndrome is not determined. Sweet's syndrome may occur at the sites of biopsy, vaccination, intravenous catheter placement, injection, as well as insect bites and cat scratches.[2] Sweet's syndrome lesions can also occur in areas that have received radiation therapy, locations that have been in contact with sensitizing antigens, places that have received pressure, and regions damaged by sunburn.[2] In our case, the lesions were clearly related to intravenous injection.
  10 in total

Review 1.  Sweet's syndrome and erythema nodosum: a companionship or a spectrum?--a case report with review of the literature.

Authors:  Duru Tabanlioğlu; Gonca Boztepe; Gül Erkin; Ozay Gököz; Ayşen Karaduman
Journal:  Int J Dermatol       Date:  2010-01       Impact factor: 2.736

Review 2.  Erythema nodosum.

Authors:  Juan Mana; Joaquim Marcoval
Journal:  Clin Dermatol       Date:  2007 May-Jun       Impact factor: 3.541

Review 3.  Neutrophilic dermatoses: part I.

Authors:  Renan Rangel Bonamigo; Fernanda Razera; Gislaine Silveira Olm
Journal:  An Bras Dermatol       Date:  2011 Jan-Feb       Impact factor: 1.896

4.  Sweet's syndrome: study of 73 cases, emphasizing histopathological findings.

Authors:  Mayra Carrijo Rochael; Luciana Pantaleão; Enoï A Guedes Vilar; Luciana Helena Zacaron; Eduardo Quelhas Spada; Marcus H S B Xavier; Karla Strong Rodrigues
Journal:  An Bras Dermatol       Date:  2011 Jul-Aug       Impact factor: 1.896

5.  Sweet's syndrome: clinicopathological features of patients treated from 1997 to 2009 at Cassiano Antonio Moraes University Hospital - Vitoria (Espirito Santo).

Authors:  Itamara Assini Eleuterio; Ricardo Montibeler Tiussi; Delio Delmaestro; Lucia Martins Diniz; Elton Almeida Lucas
Journal:  An Bras Dermatol       Date:  2012 May-Jun       Impact factor: 1.896

Review 6.  The skin pathergy test: innately useful?

Authors:  Alexandra Varol; Oliver Seifert; Chris D Anderson
Journal:  Arch Dermatol Res       Date:  2009-12-12       Impact factor: 3.017

Review 7.  Subcutaneous sweet syndrome.

Authors:  Guillermo Guhl; Amaro García-Díez
Journal:  Dermatol Clin       Date:  2008-10       Impact factor: 3.478

8.  Concurrent occurrence of Sweet's syndrome and erythema nodosum: an overlap in the spectrum of reactive dermatoses.

Authors:  Sanjeev Wasson; Gurushanker Govindarajan; Darcy Folzenlogen
Journal:  Clin Rheumatol       Date:  2005-05-18       Impact factor: 2.980

9.  Sweet's syndrome and erythema nodosum: two neutrophilic dermatoses?

Authors:  M Ginarte; J Toribio
Journal:  Clin Rheumatol       Date:  2007-02-10       Impact factor: 3.650

Review 10.  Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.

Authors:  Philip R Cohen
Journal:  Orphanet J Rare Dis       Date:  2007-07-26       Impact factor: 4.123

  10 in total
  1 in total

Review 1.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.